American Tungsten & Antimony LtdASX: AT4

Dr Ivy Estabrooke Appointed Director and Appendix 3X

Oct 18, 2026 at 5:07 PM EDT · Issued by American Tungsten & Antimony Ltd via ASX

Filed with ASX · Oct 18, 2026 at 5:07 PM EDT

On 6ix: 6ix.com/news/dr-ivy-estabrooke-appointed-director-and-appendix-3x

19 October 2026 AMERICAN TUNGSTEN & ANTIMONY LTD ACN 168 269 752 A 15B/531 Hay Street, Subiaco WA 6008 Australia P +61 (08) 6256 4403 | E info@ataa.com | W www.ataa.com Page 1 of 3 AT4 APPOINTS US DEFENCE SUPPLY CHAIN AND CRITICAL MINERALS EXECUTIVE TO BOARD Dr Ivy Estabrooke brings US...

View Attachment

6ix hasn’t read this filing yet.

American Tungsten & Antimony Ltd on 6ix

Story so far

Appendix 4G and Corporate Governance StatementSep 29, 2026
Quarterly Activities/Appendix 5B Cash Flow ReportJul 31, 2026

Earlier from American Tungsten & Antimony

Becoming a substantial holder for EUZOct 16
Antimony and Silver Results Support Mine-to-Metal StrategyOct 14
Regulus II Antimony Grade Exceeded at Del SolOct 12
Change of Company AddressOct 9
Annual Report to shareholdersSep 29

Later from American Tungsten & Antimony

Trading HaltOct 25
Suspension from QuotationOct 27
AT4 Completes Acquisition of Del Sol RefineryOct 29
Reinstatement to QuotationOct 29
Notice of AGM/Proxy Form/Shareholder LetterOct 30

All American Tungsten & Antimony news releases

Follow American Tungsten & Antimony into a list and get an email when it puts out news.

Follow American Tungsten & Antimony